German China

Providers on the topic

On 1 and 2 December 2026, the T3 – Transform The Tomorrow conference will explore strategies that help companies future-proof their operations. (Bild: © Vogel Corporate Solutions / AdobeStock 1280236166, Oksana)
Event Preview

T3 – Transform The Tomorrow: Why the Future Demands the Courage to Transform

Artificial intelligence, robotics, new business models, and evolving customer expectations are reshaping business and industry at an unprecedented pace. For leaders, simply reacting to change is no longer enough. What is required are strategic decisions that make organizations resilient, innovative, and future-ready. Transformation is no longer optional. It is a leadership responsibility. This will be the focus of the T3 Conference 2026.

Read on
Metastatic BAP1-deficient melanoma is the most common intraocular malignancy in adults, but it remains rare and extremely difficult to treat once it spreads.  (Source: Turun yliopisto/University of Turku)
Lab Tools

New Lab Model to Study Rare and Deadly Melanomas

Researchers have developed a new laboratory model to study rare tumors—BAP1-deficient melanomas—that are resistant to immunotherapies. The model has the potential to transform how therapies are developed for aggressive melanomas that currently have almost no effective treatment options.

Read on